Physician profile
Devi K Pierce
NPI 1144218496
$553.35
in general payments reported to CMS, 2019-2025
17 companies · $285 in 2025
The $285 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.14 · 2021: $16.11 · 2022: $91.28 · 2023: $69.11 · 2024: $76.82 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404 · Education: $26.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.94 |
| Education | $26.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $73.68 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $70.52 | 2022-2025 | Airsupra, Breztri |
| Nevro Corp. | $39.12 | 2024 | Senza |
| Lilly USA, LLC | $36.41 | 2022-2025 | Zepbound, Mounjaro |
| Abbvie INC. | $34.97 | 2022-2025 | |
| Pacira Pharmaceuticals Incorporated | $34.23 | 2025 | Iovera |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.25 | 2020-2021 | |
| Pfizer INC. | $30.80 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $29.35 | 2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.67 | 2022-2023 | Trulance, Xifaxan |
| Xeris Pharmaceuticals, INC. | $26.88 | 2023 | Gvoke Hypopen |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $24.97 | 2025 | Caplyta |
| Nestle Healthcare Nutrition INC. | $22.14 | 2022 | |
| Exact Sciences Corporation | $20.10 | 2025 | Cologuard Collection Kit |
| Spr Therapeutics, INC | $19.79 | 2024 | Sprint Pns System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $17.91 | 2024 | Standard Rf Disposables |
| Mylan Specialty L.P. | $13.56 | 2023 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devi Pierce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.